Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT)
The summary for the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Advanced Research Projects Agency for Health, which is the U.S. government agency offering this grant.
Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT): 10 APRIL 2024: The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.Interested parties are invited to review the attached PRINT Innovative Solutions Opening (ISO) ARPA-H-SOL-24-101.27 MARCH 2024: The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program. ARPA-H anticipates multiple awards and award types will result from this announcement. ARPA-H will host a Proposer’s Day on May 07, 2024. The event will allow for both in-person and virtual participation and is intended to facilitate teaming and foster a greater understanding of the PRINT Program. The closing date for registration is April 30, 2024, 1:00 PM ET. In-person attendance is first-come, first-served or when capacity is reached. After reviewing the attached Proposers’ Day information, interested parties are encouraged to register at the link below.https://arpa-h.gov/research-and-funding/programs/printSolution Summary Due Date and Time: May 28, 2024, 9:00 AM ET Proposals will be by invitation only. Proposal Due Date and Time: July 8, 2024, 5:00 PM ETFor more information about ARPA-H, please visit https://arpa-h.gov
Federal Grant Title: | Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) |
Federal Agency Name: | Advanced Research Projects Agency for Health (HHS-ARPAH) |
Grant Categories: | Science and Technology and other Research and Development |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | ARPA-H-SOL-24-101 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.384 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | July 8th, 2024 |
Original Application Deadline: | July 8th, 2024 |
Posted Date: | April 10th, 2024 |
Creation Date: | April 10th, 2024 |
Archive Date: | August 7th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | April 10th, 2024 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Link to Full Grant Announcement
- SAM.gov posting
- Grant Announcement Contact
- Georgina Perry
Grantor
Phone 2409213757
PRINT Program Team - Similar Government Grants
- • Ocular Laboratory for Analysis of Biomarkers (OCULAB)
- • Groundbreaking Lymphatic Interventions and Drug Exploration
- • Lymphatic Imaging, Genomic, and pHenotyping Technologies (LIGHT) Program
- • Health Science Futures: Office-Wide Innovative Solutions Opening for Advanced Research Pro...
- • Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research P...
- • NITRO BAA
- • ARPA-H Open Office BAA
- • NITRO OA Model Symposium
- More Grants from the Advanced Research Projects Agency for Health
- • Ocular Laboratory for Analysis of Biomarkers (OCULAB)
- • Groundbreaking Lymphatic Interventions and Drug Exploration
- • Lymphatic Imaging, Genomic, and pHenotyping Technologies (LIGHT) Program